Abeona Therapeutics Inc. - Common Stock (NQ:ABEO)

5.030 +0.020 (+0.40%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abeona Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 08, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 04, 2022

Gainers Calyxt (NASDAQ:CLXT) shares rose 12.4% to $1.63 during Friday's pre-market session. The company's market cap stands at $62.7 million. Better Therapeutics (...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 02, 2022

Gainers Syros Pharmaceuticals (NASDAQ:SYRS

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 12, 2022

Gainers Biomerica (NASDAQ:BMRA) stock inc...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 07, 2022

Gainers Absci (NASDAQ:ABSI) shares increased by 51.5% to $9.3 during Friday's pre-market session. The market value of their outstanding shares is at $861.1 million....

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 30, 2021

Gainers Kiora Pharmaceuticals (NASDAQ:KPRX) stock moved upwards by 20.4% to $1.06 during Thursday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 27, 2021

Gainers OptiNose (NASDAQ:OPTN) shares mov...

Via Benzinga

Mid-Afternoon Market Update: Crude Oil Drops Over 2%; Bottomline Technologies Shares Spike Higher ↗

December 17, 2021

Toward the end of trading Friday, the Dow traded down 0.87% to 35,585.26 while the NASDAQ rose 0.43% to 15,245.07. The S&P also fell, dropping 0.32% to 4,653.92. The U.S. has...

Via Benzinga

63 Biggest Movers From Friday ↗

December 20, 2021

Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 17, 2021

Gainers Genfit (NASDAQ:GN...

Via Benzinga

Mid-Day Market Update: Dow Tumbles 500 Points; Abeona Therapeutics Shares Plummet ↗

December 17, 2021

Midway through trading Friday, the Dow traded down 1.39% to 35,398 while the NASDAQ fell 0.30% to 15,134.89. The S&P also fell, dropping 0.92% to 4,625.58. The U.S. has the...

Via Benzinga

28 Stocks Moving In Friday's Mid-Day Session ↗

December 17, 2021

Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. X4 Pharmaceuticals, Inc...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 17, 2021

Gainers Genfit (NASDAQ:GNFT) stock moved upwards by 38.55% to $4.6 during Friday's pre-market session. The market value of their outstanding shares is at $210.4...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

December 17, 2021

Good morning, investor! We're in the home stretch of the week as we tackle the biggest pre-market stock movers for Friday!

Via InvestorPlace

20 Stocks Moving in Friday's Pre-Market Session ↗

December 17, 2021

Gainers Genfit SA (NASDAQ: GNFT) rose 47.5% to $4.90 in pre-market trading. Ipsen and GENFIT reported an exclusive licensing agreement for Elafibranor. Spruce Biosciences, Inc. (...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 16, 2021

Gainers Eloxx Pharmaceuticals (NASDAQ:

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 02, 2021

Good morning, trader! We're gearing up for another busy day of trading with the biggest pre-market stock movers for Thursday!

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2021 ↗

November 30, 2021

Upgrades Sidoti & Co. upgraded the previous rating for DMC Global Inc (NASDAQ:

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

November 29, 2021

Citigroup cut Merck & Co., Inc. (NYSE: MRK) price target from $105 to $85. Merck shares fell 2% to $77.55 in pre-market trading. Keybanc lowered Arista Networks, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug ↗

November 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Synlogic Presents Positive Phase 2 Data For Synthetic Biologic Treatment In...

Via Benzinga

The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week ↗

November 21, 2021

Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 15, 2021

Welcome back, trader! We're getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday!

Via InvestorPlace

The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO ↗

October 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine...

Via Benzinga

The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs ↗

October 18, 2021

Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news....

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 05, 2021

Gainers Synaptogenix (NASDAQ:SNPX) stock...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs ↗

September 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...

Via Benzinga

Abeona Stock Gains As It Concludes Type B Meeting With FDA For MPS IIIA Gene Therapy ↗

July 28, 2021

Abeona Therapeutics Inc (NASDAQ: ABEO) has completed a Type B meeting with the FDA regarding the pivotal trial for its ABO-102 gene therapy for Sanfilippo syndrome...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 28, 2021

Gainers Infinity Pharmaceuticals (NASDAQ:INFI) shares moved upwards by 40.13% to $2.13 during Wednesday's pre-market session. The company's market cap stands at $...

Via Benzinga

34 Stocks Moving in Tuesday's Pre-Market Session ↗

July 27, 2021

Gainers Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) shares rose 139.7% to $7.48 in pre-market trading after the company announced it entered a non-binding letter of intent to...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.